Stem Cell breakthrough in India’s Kolkata hospital
In what can be stated to be a huge feat for India, stem cell treatment in a Kolkata hospital drew it further into limelight.
Kolkata: In what can be stated to be a huge feat for India, stem cell treatment in a Kolkata hospital threw it further into limelight.
Netaji Subhash Chandra Bose Cancer Research Institute carried out a remarkable transplant from an unrelated donor on Sunday. Cord blood from an infant was transferred to a patient Amal Majumdar who was suffering from aplastic anaemia.
Aplastic anaemia is a condition where bone marrow does not produce sufficient new cells to replenish blood cells.
Japan was the first to break this barrier whose success rate so far has been 80%.
According to the director of the institute, Ashish Mukherjee, “This is a path-breaking event because neither the patient’s blood group nor HLA matched with the new born girl whose stem cells are about to give Amal a new lease of life.Since cord blood stem cells have less antigenic property, they can be used without a blood group or genetic match. But for bone marrow transplant we need an HLA match.”
What is amazing is that while the donor’s blood group is A+, the recipient’s is O+.
Doctors say that it’ll take a year for the patient to fully recuperate.